603387 Getein Biotech,Inc
- 8.67
- -0.27-3.02%
Getein Biotech,Inc News
Egg Biotech: Announcement on the holding of an online briefing session on the results for the third quarter of 2024
Basic Egg Biology: Base Egg Biology: Notice on Formulating Systems Related to Corporate Governance
Basic Egg Biology: Base Egg Biology: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Directors
Basic Egg Biology: Base Egg Biology: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Supervisors
Base Egg Biology: Base Egg Bio: Announcement on holding the results briefing for the third quarter of 2024
Egg Biology: Company shares held by directors, supervisors and senior management and its change management system
Egg Biology: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Directors
Egg Biology: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Supervisors
Egg Biotech: Announcement on holding the results briefing for the third quarter of 2024
Basic Egg Biology: Base Egg Biology: Announcement on the holding of the 2024 semi-annual results online briefing
Egg Biology: Announcement on the holding of an online briefing session on the 2024 semi-annual results
Egg Biology: Announcement of Resolutions of the Third Meeting of the Fourth Board of Supervisors
Egg Biology: Announcement of Resolutions of the Third Meeting of the Fourth Board of Directors
Basic Egg Biology: Announcement on changes in accounting policies
Basic Egg Biology: Public Opinion Management System
Basic Egg Biology: Information Disclosure Management Measures (Revised in August 2024)
Basic Egg Biotech: Management System for Repurchase of Shares
Reply to the information disclosure regulatory letter from Notary Tianye Accounting Firm (Special General Partnership) on Getein Biotech, Inc.'s 2023 annual report.
Getein Biotech,Inc: Announcement on the holding of an online briefing session on the results for the 2023 and the first quarter of 2024
Getein Biotech,Inc: 2023 Accounting Firm Performance Assessment Report
Analysis
Price Target
No Data
No Data